Targeting the epigenetic machinery of cancer cells

M F Montenegro1, L Sánchez-del-Campo2, M P Fernández-Pérez1

  • 1Department of Biochemistry and Molecular Biology A, University of Murcia, Murcia, Spain.

Oncogene
|January 29, 2014
PubMed

Insights

Targeting epigenetic alterations in cancer, including aberrant methylation, offers novel therapeutic strategies. Manipulating methionine metabolism could enhance anticancer therapies by promoting apoptosis and reducing metastasis.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Cancer involves uncontrolled cell growth and metastasis, often due to oncogene activation or tumor suppressor gene inactivation.
  • Aberrant regulation of methylation, including DNA, histones, and nonhistone proteins, is increasingly linked to tumorigenesis.
  • Methionine metabolism is crucial for many methylation reactions involved in cancer development.

Purpose of the Study:

  • To explore the potential of targeting epigenetic machinery in cancer cells for novel anticancer therapies.
  • To investigate the role of aberrant methylation in cancer biology and development.
  • To highlight the therapeutic utility of epigenetic modifications in cancer treatment.

Main Methods:

  • Reviewing evidence linking aberrant methylation patterns to cancer.
  • Analyzing the role of methionine metabolism in cellular methylation processes.
  • Evaluating the potential of epigenetic therapies for cancer treatment.

Main Results:

  • Aberrant methylation of DNA, histones, and nonhistone proteins is implicated in cancer.
  • Methionine metabolic cycling is a key pathway for methylation reactions in cancer cells.
  • Targeting epigenetic machinery offers potential for novel anticancer therapies.

Conclusions:

  • Strategies targeting epigenetic machinery, particularly methylation, hold promise for effective cancer therapies.
  • Epigenetic therapies could promote cancer cell apoptosis (programmed cell death) via E2F1.
  • These therapies may also help prevent cancer metastasis and sensitize tumors to radiotherapy.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.5K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
28.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K